New York City City-based NYU Langone Transplant Institute and Hassenfeld Childrens Hospital have actually released a brand-new pediatric heart failure and transplant program, expanding regional access to specialized care for children.
Gabrielle Masson –
Friday, September 18th, 2020
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by click on this link.
The program is led by Rakesh Singh, MD, pediatric cardiologist and medical director of pediatric cardiac arrest and hair transplant at NYU Langone, and T.K. Susheel Kumar, MD, pediatric heart cosmetic surgeon and surgical director of cardiothoracic surgical treatment.
More articles on cardiology:6 cardiologists on the moveThe state of cardiology and where its headed: 4 patterns to know25-physician cardiology group to sign up with St. Peters Health Partners.
NYU Langones Pediatric Congenital Heart Program has a 99 percent survival rate, exceeding the national average, according to 2015-19 information from the Society of Thoracic Surgeons. The Transplant Institute has the leading adult heart transplant program in the U.S., according to data from the Scientific Registry of Transplant Recipients based on fast transplant rates, low death while waiting for transplant and 1 year post-transplant survival rates.
This is the fifth brand-new strong organ transplant program gone for NYU Langone considering that 2017. Current research has concentrated on making use of organs that may otherwise be declined and establishing brand-new protocols such as strategies to enable organ contribution after cardiac death.